CA3067294A1 - Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders - Google Patents
Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders Download PDFInfo
- Publication number
- CA3067294A1 CA3067294A1 CA3067294A CA3067294A CA3067294A1 CA 3067294 A1 CA3067294 A1 CA 3067294A1 CA 3067294 A CA3067294 A CA 3067294A CA 3067294 A CA3067294 A CA 3067294A CA 3067294 A1 CA3067294 A1 CA 3067294A1
- Authority
- CA
- Canada
- Prior art keywords
- heat
- pooled human
- phpl
- human platelet
- platelet lysate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305739 | 2017-06-16 | ||
| EP17305739.9 | 2017-06-16 | ||
| PCT/EP2018/066020 WO2018229278A1 (en) | 2017-06-16 | 2018-06-15 | Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3067294A1 true CA3067294A1 (en) | 2018-12-20 |
Family
ID=59269973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3067294A Pending CA3067294A1 (en) | 2017-06-16 | 2018-06-15 | Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11744863B2 (https=) |
| EP (1) | EP3638263B1 (https=) |
| JP (1) | JP7370870B2 (https=) |
| CN (1) | CN110891582A (https=) |
| AU (1) | AU2018284011B2 (https=) |
| BR (1) | BR112019026846A2 (https=) |
| CA (1) | CA3067294A1 (https=) |
| ES (1) | ES2955282T3 (https=) |
| IL (1) | IL271436B2 (https=) |
| WO (1) | WO2018229278A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI744300B (zh) * | 2016-03-23 | 2021-11-01 | 里爾中央醫學中心 | 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途 |
| EP3920944A4 (en) * | 2019-02-07 | 2023-03-29 | Biobridge Global | METHODS AND COMPOSITIONS RELATED TO PLATELET RELEASTAT AND PLATELET-RICH FIBRIN |
| EP3881858A1 (en) * | 2020-03-20 | 2021-09-22 | Rok Pangersic | Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect |
| WO2023103744A1 (zh) * | 2021-12-07 | 2023-06-15 | 无限发展有限公司 | 血小板内生长因子的提取方法 |
| EP4276173A1 (en) | 2022-05-10 | 2023-11-15 | Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. | Stable human platelet lysate composition, methods and uses thereof |
| AU2022489599A1 (en) * | 2022-12-02 | 2025-07-17 | Nuwacell Biotechnologies Co., Ltd. | Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells |
| TWI909123B (zh) | 2022-12-30 | 2025-12-21 | 思必瑞特生技股份有限公司 | 含血小板之組合物及其製備方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2006632A6 (es) | 1987-04-21 | 1989-05-01 | Green Cross Corp | Procedimiento de tratamiento termico de fibrinogeno. |
| GB0512401D0 (en) * | 2005-06-17 | 2005-07-27 | Randox Lab Ltd | Method |
| WO2008034803A1 (en) * | 2006-09-18 | 2008-03-27 | Medizinische Universität Graz | Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics |
| EP2077118A1 (en) * | 2008-01-07 | 2009-07-08 | Gwo Rei Biomedical Technology Corp. | Clottable concentrate of platelet growth factors and preparation method thereof |
| ES2402144T3 (es) * | 2010-05-25 | 2013-04-29 | Gwowei Technology Co., Ltd. | Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación |
| IL210162A0 (en) | 2010-12-21 | 2011-03-31 | Omrix Biopharmaceuticals | Viral inactivated platelet extract, use and preparation thereof |
| CA2840568C (en) | 2011-06-27 | 2021-05-04 | Emory University | Compositions, uses, and preparation of platelet lysates |
| US20140176602A1 (en) | 2011-08-18 | 2014-06-26 | Nec Corporation | Information processing system, information processing method, information processing apparatus, and control method and control program thereof |
| AU2013365623B2 (en) * | 2012-12-20 | 2017-08-24 | Omrix Biopharmaceuticals Ltd. | Viral inactivated biological mixture |
| WO2015031465A1 (en) | 2013-08-27 | 2015-03-05 | Cook General Biotechnology Llc | Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same |
-
2018
- 2018-06-15 IL IL271436A patent/IL271436B2/en unknown
- 2018-06-15 EP EP18732057.7A patent/EP3638263B1/en active Active
- 2018-06-15 US US16/622,446 patent/US11744863B2/en active Active
- 2018-06-15 WO PCT/EP2018/066020 patent/WO2018229278A1/en not_active Ceased
- 2018-06-15 CA CA3067294A patent/CA3067294A1/en active Pending
- 2018-06-15 CN CN201880047062.4A patent/CN110891582A/zh active Pending
- 2018-06-15 ES ES18732057T patent/ES2955282T3/es active Active
- 2018-06-15 AU AU2018284011A patent/AU2018284011B2/en active Active
- 2018-06-15 BR BR112019026846-4A patent/BR112019026846A2/pt active Search and Examination
- 2018-06-15 JP JP2019569741A patent/JP7370870B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11744863B2 (en) | 2023-09-05 |
| US20200113942A1 (en) | 2020-04-16 |
| EP3638263A1 (en) | 2020-04-22 |
| ES2955282T3 (es) | 2023-11-29 |
| EP3638263C0 (en) | 2023-08-23 |
| RU2020101295A3 (https=) | 2022-02-24 |
| BR112019026846A2 (pt) | 2020-06-30 |
| CN110891582A (zh) | 2020-03-17 |
| AU2018284011B2 (en) | 2024-05-30 |
| IL271436B2 (en) | 2024-02-01 |
| JP2020523398A (ja) | 2020-08-06 |
| IL271436B1 (en) | 2023-10-01 |
| AU2018284011A1 (en) | 2020-01-16 |
| IL271436A (en) | 2020-01-30 |
| WO2018229278A1 (en) | 2018-12-20 |
| EP3638263B1 (en) | 2023-08-23 |
| RU2020101295A (ru) | 2021-07-16 |
| JP7370870B2 (ja) | 2023-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018284011B2 (en) | Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders | |
| US11786556B2 (en) | Method for preparing a growth factors containing platelet releasate | |
| AU2017238476B2 (en) | Preparation of platelet pellet lysate and its use for treating neurological disorders | |
| US20230135837A1 (en) | Process for preparing a platelet lysate fraction, platelet lysate fraction and its use for treating disorders of the central nervous system | |
| US20170252372A1 (en) | Viral inactivated biological mixture | |
| RU2802440C2 (ru) | Способ получения объединенного лизата тромбоцитов человека, объединенный лизат тромбоцитов человека и его применение для лечения неврологических нарушений | |
| Nandikolmath et al. | Preparation of bio-bandage from human platelet lysate admixed with sericin polymer for efficient wound healing | |
| Jinbo et al. | Olfactory ensheathing cell-conditioned medium protects astrocytes exposed to hydrogen peroxide stress | |
| Goczyńska et al. | Innovative applications of platelet derivatives in light of information presented during the 2022 virtual congress of the International Society of Blood Transfusion (ISBT); selected issues | |
| HK1195486A (en) | Viral inactivated platelet extract, use and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230530 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20240912 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250109 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250522 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250522 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20260122 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20260122 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20260218 |